Biopico’s OrganRX system is the world’s first unidirectional gravity-driven flow multiorgan system in a multiwell plate format. We welcome researchers interested in toxicity/pharmacological studies or organ model development for disease pathology to discuss how our OrganRX Plate will contribute to their research. In addition, we will guide how our system can help your research for precision in vitro studies. Founded in 2011, Biopico Systems Inc operates in the biotechnology, manufacturing, and marketing industries, with its headquarters in the United States. Their last investment, a $150.00K grant investment, was received on 13 November 2013 from the National Science Foundation.
General Information
Get notified when Biopico Systems INC moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Biopico Systems INC
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Biopico Systems INC
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
13 Nov 2013 |
Biopico Systems INC Alternatives & Competitors
Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human
FAQ About Biopico Systems INC
Don't just browse. Track.
Signal Tracker monitors Biopico Systems INC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.